MUMBAI: The Bombay High Court on Tuesday granted relief to Cadila Pharmaceuticals Ltd while pulling up the Maharashtra Food and Drug Administration (FDA) for stopping the sale and distribution of some of its medicines and seizing its stocks, observing that the regulatory authority was just “displaying its powers” through such action | Mumbai news

The Bombay High Court criticized the Maharashtra FDA for its drastic actions against companies. The court directed the regulator to grant hearings before taking severe measures.…

Bombay HC urges FDA to exercise restraint, ensuring pharmaceutical companies receive fair hearings before regulatory actions.